Pulse Biosciences Stock Price

-0.15 (-7.01%)
Volume 175,790
Bid Price 1.95
Ask Price 2.29
News -
Day High 2.23


52 Week Range


Day Low 1.95
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
Level 1 Starter
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Pulse Biosciences Inc PLSE NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.15 -7.01% 1.99 17:47:12
Open Price Low Price High Price Close Price Prev Close
2.23 1.95 2.23 1.99 2.14
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
1,652 175,790 $ 2.03 $ 357,429 - 1.405 - 29.16
Last Trade Time Type Quantity Stock Price Currency
16:15:56 formt 100 $ 1.76 USD


Draw Mode:

Pulse Biosciences Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 59.31M 29.80M 14.10M $ 1.42M $ - -2.29 -1.00
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 325.96k 51.20%

more financials information »

Pulse Biosciences News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical PLSE Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week1.562.391.462.01388,7650.4327.56%
1 Month4.054.051.4052.41273,422-2.06-50.86%
3 Months5.285.741.4053.52254,319-3.29-62.31%
6 Months21.5821.801.4056.16191,758-19.59-90.78%
1 Year17.6829.161.40510.37132,248-15.69-88.74%
3 Years12.3445.821.40513.79104,264-10.35-83.87%
5 Years25.8345.821.40516.65116,823-23.84-92.3%

Pulse Biosciences Description

Pulse Biosciences Inc is a medical therapy company that pursues the commercial introduction of its proprietary CellFX System utilizing its patent-protected Nano-Pulse Stimulation (NPS) platform technology. Through its proprietary CellFX System, the company can deliver a cell-focused effect on dysfunctional cells while preserving surrounding non-cellular tissue, a combination that may potentially lead to both improved efficacy and less collateral tissue damage. Substantial revenue is generated from North America Majorly due to the sale of systems.

Your Recent History
Pulse Bios..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.